Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [68Ga]Ga-Pentixafor/[177Lu]Lu-Pentixather
Sarah M. Jacobs et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA1receptor
Rackele F. Amaral et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies
Luiz Henrique Medeiros Geraldo et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures
Tian Hua et al.
CELL (2020)
Biological activity of weekly ONC201 in adult recurrent glioblastoma patients
Isabel Arrillaga-Romany et al.
NEURO-ONCOLOGY (2020)
Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma
Melinda N. Tea et al.
CANCERS (2020)
FTY720 Exerts Anti-Glioma Effects by Regulating the Glioma Microenvironment Through Increased CXCR4 Internalization by Glioma-Associated Microglia
Xu-Dong Guo et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Role of Selected Chemokines and Their Receptors in the Development of Gliomas
Magdalena Groblewska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Opportunities and challenges for drug discovery in modulating Adhesion G protein-coupled receptor (GPCR) functions
Andrey D. Bondarev et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Mechanisms of adhesion G protein-coupled receptor activation
Alexander Vizurraga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Cannabinoids and Cannabinoid Receptors: The Story so Far
Fred Shahbazi et al.
ISCIENCE (2020)
Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate
Cyntanna C. Hawkins et al.
BIOMOLECULES (2020)
Atypical chemokine receptors in tumor cell growth and metastasis
Bal L. Lokeshwar et al.
GPCR SIGNALING IN CANCER (2020)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2020)
Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer
Tovi Shapira-Furman et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
Ulrich Herrlinger et al.
LANCET (2019)
GPCR Signaling Regulation: The Role of GRKs and Arrestins
Vsevolod V. Gurevich et al.
FRONTIERS IN PHARMACOLOGY (2019)
Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy
Victoria Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme
Zbynek Novy et al.
MOLECULES (2019)
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
Olivia G. Taylor et al.
FRONTIERS IN ONCOLOGY (2019)
Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside
Yan Xu
CANCERS (2019)
A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment
Da Wang et al.
DRUG DELIVERY (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo
Francesca Vaglini et al.
MOLECULAR NEUROBIOLOGY (2018)
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy
Francesco Pasqualetti et al.
MOLECULAR NEUROBIOLOGY (2018)
Pharmacogenomics of GPCR Drug Targets
Alexander S. Hauser et al.
CELL (2018)
Development of Novel Therapeutics Targeting Isocitrate Dehydrogenase Mutations in Cancer
Horrick Sharma
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Adhesion G Protein-Coupled Receptors as Drug Targets
Ryan H. Purcell et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
The Hypoxic Tumor Microenvironment Promotes Invadopodia Formation and Metastasis through LPA1 Receptor and EGFR Cooperation
Kelly Harper et al.
MOLECULAR CANCER RESEARCH (2018)
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Krishna Sriram et al.
MOLECULAR PHARMACOLOGY (2018)
WHO 2016 Classification of gliomas
P. Wesseling et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs
Claudia A. Dumitru et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Cancer Cell Mechanics: Adhesion G Protein-coupled Receptors in Action?
Nicole Scholz
FRONTIERS IN ONCOLOGY (2018)
New approaches and challenges to targeting the endocannabinoid system
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2018)
Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity
Heng Zhang et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with Tc-99m and Lu-177 as Potential Receptor Radiopharmaceuticals
Agnieszka Majkowska-Pilip et al.
MOLECULES (2018)
Treatment of glioblastoma in adults
Wolfgang Wick et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Cancer stem cells as key drivers of tumour progression
Ain Zubaidah Ayob et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
Giovanni Luca Gravina et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma
Mark W. Kieran et al.
NEURO-ONCOLOGY (2017)
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine
Katharina J. Wenger et al.
ONCOLOGY LETTERS (2017)
Glioblastoma: new therapeutic strategies to address cellular and genomic complexity
Xue Cai et al.
Oncotarget (2017)
Visualizing the GPCR Network: Classification and Evolution
Geng-Ming Hu et al.
SCIENTIFIC REPORTS (2017)
Smoothened is a poor prognosis factor and a potential therapeutic target in glioma
Yiming Tu et al.
SCIENTIFIC REPORTS (2017)
Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells
Richard E. Kast et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
An Introduction to the Endogenous Cannabinoid System
Hui-Chen Lu et al.
BIOLOGICAL PSYCHIATRY (2016)
Lysophospholipids and their G protein-coupled receptors in atherosclerosis
Ya-Feng Li et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2016)
G protein-coupled receptor kinases as regulators of dopamine receptor functions
Eugenia V. Gurevich et al.
PHARMACOLOGICAL RESEARCH (2016)
Origin of the U87MG glioma cell line: Good news and bad news
Marie Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Smoothened Regulation: A Tale of Two Signals
Angela M. Arensdorf et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Sunitinib: the antiangiogenic effects and beyond
Zhonglin Hao et al.
ONCOTARGETS AND THERAPY (2016)
Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significance
Maria Pyszniak et al.
ONCOTARGETS AND THERAPY (2016)
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
Jin-Ku Lee et al.
ONCOLOGY LETTERS (2016)
GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth
N. S. Bayin et al.
ONCOGENESIS (2016)
Long-term survival in a patient with glioblastoma on antipsychotic therapy for schizophrenia: a case report and literature review
Shahdabul Faraz et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)
Identification of Novel Smoothened Ligands Using Structure-Based Docking
Celine Lacroix et al.
PLOS ONE (2016)
A phase I study of chemo-radiotherapy with plerixafor for newly diagnosed glioblastoma (GB).
Reena Parada Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Oligodendroglioma: pathology, molecular mechanisms and markers
Pieter Wesseling et al.
ACTA NEUROPATHOLOGICA (2015)
Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
Sajeel A. Chowdhary et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
Sadaharu Tabuchi
LIPIDS IN HEALTH AND DISEASE (2015)
Increasing feasibility and utility of 18F-FDOPA PET for the management of glioma
Christopher Bell et al.
NUCLEAR MEDICINE AND BIOLOGY (2015)
On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines
A. Ortega et al.
TOXICOLOGY IN VITRO (2015)
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
Elena Ciaglia et al.
ONCOTARGET (2015)
Biological and Pharmacological Aspects of the NK1-Receptor
Susana Garcia-Recio et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats
M. J. Walters et al.
BRITISH JOURNAL OF CANCER (2014)
Long-term treatment with temozolomide in malignant glioma
Jonathan P. Mannas et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2014)
Thematic Review Series: Lysophospholipids and their Receptors LPA receptor signaling: pharmacology, physiology, and pathophysiology
Yun C. Yung et al.
JOURNAL OF LIPID RESEARCH (2014)
G PROTEIN-COUPLED RECEPTORS AS ONCOGENIC SIGNALS IN GLIOMA: EMERGING THERAPEUTIC AVENUES
A. E. Cherry et al.
NEUROSCIENCE (2014)
IDH1 and IDH2 Mutations in Gliomas
Adam L. Cohen et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Expression and Functional Heterogeneity of Chemokine Receptors CXCR4 and CXCR7 in Primary Patient-Derived Glioblastoma Cells
Che Liu et al.
PLOS ONE (2013)
Physiology and Pharmacology of Plerixafor
Simon P. Fricker
TRANSFUSION MEDICINE AND HEMOTHERAPY (2013)
IDH1 and IDH2 Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives
Hui Yang et al.
CLINICAL CANCER RESEARCH (2012)
Cannabinoids, endocannabinoids, and cancer
Daniel J. Hermanson et al.
CANCER AND METASTASIS REVIEWS (2011)
Atypical chemokine receptors
Maria Helena Ulvmar et al.
EXPERIMENTAL CELL RESEARCH (2011)
Effects of Lysophospholipids on Tumor Microenvironment
Johannes Rolin et al.
CANCER MICROENVIRONMENT (2011)
The Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
Ya-Xiong Tao
ENDOCRINE REVIEWS (2010)
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms
O. Kosmider et al.
LEUKEMIA (2010)
EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target
Ari J. Kane et al.
NEUROREPORT (2010)
CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities
Charles B. Stevenson et al.
NEUROSURGERY (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism
Dagmar Meyer zu Heringdorf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Brain tumours: Classification and genes
VP Collins
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
The G-protein-coupled receptors in the human genome form five main families.: Phylogenetic analysis, paralogon groups, and fingerprints
R Fredriksson et al.
MOLECULAR PHARMACOLOGY (2003)
The WHO classification of tumors of the nervous system
P Kleihues et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Share Paper
